Navigation Links
Amgen Outlines Long-Term Strategy
Date:2/7/2013

NEW YORK, Feb. 7, 2013 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today outlined the company's long-term strategy during a Business Review meeting with analysts and investors in New York City.

Robert A. Bradway , chairman and chief executive officer at Amgen, opened the meeting by affirming the company's core strategy will continue to focus on innovation, discovery and development of breakthrough molecules to address significant unmet medical needs, and manufacturing of high-quality biologics. Bradway highlighted how certain elements of the company's strategy have evolved:

  • Research and Development (R&D): A more selective approach to R&D, embracing a "pick the winners" strategy with greater focus on human genetics to identify and validate targets, and a strong commitment to return on capital;
  • Commercial: Transformation of the commercial model with an emphasis on expanded access and value to payers, increased presence in key new and emerging markets, investment in new growth opportunities, including biosimilars, and greater product differentiation through drug delivery devices; and
  • Manufacturing: Emphasis on new manufacturing processes and technologies, driving  expanded throughput and flexibility and lower capital needs. 
  • "Amgen is in a unique position to capitalize on major advances in drug discovery and biologics manufacturing," said Bradway. "We are making strategic investments to drive long-term growth and deliver for both patients and shareholders."

    More Strategic Approach to R&D Sean E. Harper , M.D., executive vice president of Research and Development at Amgen, discussed Amgen's new strategic approach to R&D and provided highlights of the company's ongoing clinical programs.

    The company's
    '/>"/>

    SOURCE Amgen
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related medicine technology :

    1. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
    2. Four Californians Selected As Breakaway from Cancer® Champions To Be Honored During Amgen Tour of California
    3. Amgen to Present at the Baird Growth Stock Conference
    4. Amgen To Provide Testimony At FDA Stakeholder Hearing On Biosimilars
    5. Amgens BiTE® Antibody Blinatumomab (AMG 103) Achieved High Rate of Complete Response in Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
    6. Amgen Announces Top-Line Results Of Phase 3 Sensipar®/Mimpara® EVOLVE™ Trial
    7. Amgen Completes Acquisition of Mustafa Nevzat Pharmaceuticals
    8. Amgen Completes Acquisition of KAI Pharmaceuticals
    9. Amgens Second Quarter 2012 Revenues Increased 13 Percent To $4.5 Billion And Adjusted Earnings Per Share (EPS) Increased 34 Percent To $1.83
    10. Amgen Announces Termination Of Ganitumab Phase 3 Study For Futility In Metastatic Pancreatic Cancer
    11. Amgen To Present At The Baird Healthcare Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/28/2015)... 28, 2015 Research and ... the "Investigation Report on China,s Tobramycin Market, 2010-2019" ... a traditional antibiotic whose eye drop and ointment are ... potential infection or inflammation caused by eye infection. Currently, ... are able to produce tobramycin, among which the Top ...
    (Date:8/28/2015)... DUBLIN , Aug. 28, 2015 ... ) has announced the addition of the ... report to their offering. Developed by ... Seroquel) is an important drug for the treatment ... in 2000, quetiapine was listed in the Catalogue ...
    (Date:8/28/2015)... , Aug. 28, 2015 ... addition of the "Investigation Report on China,s Ranibizumab ... Developed by Novartis, ranibizumab was approved by CFDA to ... Currently, only Lucentis, a product of Novartis, is available ... the first self- developed drug for the treatment of ...
    Breaking Medicine Technology:Investigation Report on China's Tobramycin Market, 2015-2019 2China Quetiapine Market Investigation Report 2010-2019 2Investigation Report on China's Ranibizumab Market, 2012-2019 2
    ... 7, 2011 Akorn, Inc. (NASDAQ: AKRX ... 2011, to discuss third quarter 2011 results followed by a ... day before the market opens. Subject: , Akorn, Inc. ... 2011, at 10:00 a.m. Eastern TimeDomestic Callers: , (888) ...
    ... PARSIPPANY, N.J., Oct. 7, 2011 Watson Pharmaceuticals, Inc. ... subsidiary, Watson Laboratories, Inc. - Florida, filed an Abbreviated ... Drug Administration (FDA) seeking approval to market Morphine Sulfate ... mg/2 mg, 60 mg/2.4 mg, 80 mg/3.2 mg, and ...
    Cached Medicine Technology:Watson Confirms EMBEDA(R) Patent Challenge 2Watson Confirms EMBEDA(R) Patent Challenge 3
    (Date:8/29/2015)... AZ (PRWEB) , ... August 30, 2015 , ... On ... College (EMCC), one of the 10 regionally accredited Maricopa Community Colleges , ... to network with college students pursuing employment information and opportunities. , The Expo has ...
    (Date:8/29/2015)... ... August 29, 2015 , ... Targeted therapies, made ... the lives of patients, according to a newly published report. Surviving Mesothelioma has ... full article. , The authors of the new paper focus on several ...
    (Date:8/29/2015)... AB (PRWEB) , ... August 29, 2015 , ... ... heart failure, angina, chronic obstructive pulmonary disease (including emphysema), or asthma, are at ... such as angina, previous heart attack, heart failure or heart-rhythm problems (arrhythmia or ...
    (Date:8/28/2015)... ... August 28, 2015 , ... ... management, Decatur County Memorial Hospital recently transitioned management companies to partner with Wound ... Management for their outpatient wound center. , Transitioning wound care management providers ...
    (Date:8/28/2015)... ... , ... With the goal of furthering music education programs in schools, the ... County Fairgrounds in Mendon, IL on May 30th, 2015. Backed once again by Best ... the underfunded school districts of Mendon and its neighboring town of Quincy, IL. Best ...
    Breaking Medicine News(10 mins):Health News:Estrella Mountain Community College Expo Offers ‘One-Stop’ for Employers and Students Seeking Internships, Jobs, Careers and Service Learning Opportunities 2Health News:Top Mesothelioma Researchers Highlight Targeted Therapies in New Report, According to Surviving Mesothelioma 2Health News:Heart Fit Clinic Sounds the Alarm on Forest Fire Smoke and Chronic Heart Disease in Calgary Area 2Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 2Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 3Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 4Health News:Best Drug Rehabilitation Interviews Country-Rock Duo Highway Run at the 2015 "Music With A Mission" Benefit Concert 2
    ... How Eating Disorders Affect Loved Ones At ... The Remuda Cornerstone Bookstore on May 2, PHOENIX, ... the nation,s leading and largest inpatient,treatment center for women and ... with the authors of the new book "Distorted -,How a ...
    ... on human immune cell may be key to stopping infection ... at suppressing HIV target proteins lying on the virus itself, ... immune cells might work even better. , That,s because human ... the virus would have much less chance of mutating around ...
    ... More than 6,000 internists (doctors of internal medicine), ... meet in Washington, D.C., for Internal Medicine 2008, ... of Physicians (ACP), from May 15 - 17 ... Internal Medicine 2008 is the largest continuing medical ...
    ... 29 /PRNewswire-FirstCall/ - Traxxec,Ltd, the UK subsidiary of ... today announces that, in line with the licence ... at the Interpack conference,and trade show in Dusseldorf, ... will be present at this,meeting giving the Traxxec ...
    ... third of Downs syndrome children who wear bifocal lenses to ... for two years, according to new research from Cardiff University. ... Syndrome Research Unit has studied the reasons for poor focussing ... of the children in the study who adopted bifocals to ...
    ... April 29 Gunther von Hagens, BODY WORLDS, the,traveling ... this week. Though it will not be known if ... at BODY WORLDS in Los Angeles, or if,the honor ... in Milwaukee, or,Baltimore, or Manchester, England, the number is ...
    Cached Medicine News:Health News:Authors Of New Critically Acclaimed Book 'Distorted' Share Their Journey From an Eating Disorder at a Book Signing Event in Wickenburg 2Health News:Researchers Tackle HIV From a New Angle 2Health News:Researchers Tackle HIV From a New Angle 3Health News:ACP hosts largest medical education meeting for general and subspecialty internists 2Health News:Columbia River Resources Inc subsidiary, Traxxec Ltd, reports coverage of its technology at Interpack 2008 (Pink Sheets OTC - CRVR.pk) 2Health News:Columbia River Resources Inc subsidiary, Traxxec Ltd, reports coverage of its technology at Interpack 2008 (Pink Sheets OTC - CRVR.pk) 3Health News:A life 'lens' ordinary 2Health News:Gunther Von Hagens' BODY WORLDS Exhibitions Mark 25th Million Visitor Milestone 2Health News:Gunther Von Hagens' BODY WORLDS Exhibitions Mark 25th Million Visitor Milestone 3
    ... protection Properly manufactured radiation protective eyewear ... Our high quality frames and materials offer ... weight. Our lenses are made of Schott ... industry standards. Most Pulse Glasses are offered ...
    Uvex Patriot Frame...
    Panoramic styling that contours closely to the face and brow. Saddle bridge fits average to fuller noses. Adjustable temple hinge adjusts up or down, longer or shorter. Soft cushion behind ear for co...
    QualCraft™ Euro Lite has a molded nylon frame that fits most faces. Universal keyhole nose bridge fits narrow to average noses. Available with or without lead vinyl-lined side shields....
    Medicine Products: